IMIBIC-P²Med

  • HOME
  • ABOUT
    • What is IMIBIC-P2Med?
    • Programme Management
  • PROJECTS & FELLOWS
    • GLIOCHEM
    • HIDELIS
    • MEMOIR
    • ProsCanGO
    • FluVac-Tregs
    • Tac1-PCOS
  • NEWS
  • ARCHIVE
    • Fellowships
      • What we offer
      • Who can apply
      • Host institute
      • Host groups
      • Research facilities
      • Partner organisations
      • Employment conditions
    • Call for proposals 2019
      • Timetable
      • Application process
      • Eligibility
      • Evaluation process
      • Evaluation criteria
      • Application documents
      • Redress procedure
      • Frequently Asked Questions
  • HELPDESK
  • IMIBIC-MIP 2021

Follow us on ResearchGate

programme manager14 July, 202214 July, 2022 News

The project results and materials are now available also on ResearchGate.

The project page features the Fellows’ collaborative work, training and career development outputs and results of their individual projects.

Follow us!

IMIBIC-P2Med ResearchGate

communication, dissemination, fellows, FluVac-Tregs, GLIOCHEM, HIDELIS, MEMOIR, openscience, ProsCanGO, tac1-PCOS
  • ← Our first paper is out!

IMIBIC-P²Med in Twitter

IMIBIC-P2MedFollow

IMIBIC Fellowship Programme for Personalised and Precision Medicine

Avatar
Retweet on TwitterIMIBIC-P2Med Retweeted
AvatarMarieSkłodowskaCurie@MSCActions·
11 Jul

🔶 The July issue of the #MSCA Newsletter is here 🔶

Read the latest news on the MSCA ⤵️ and subscribe to be among the first to receive the next newsletter in your inbox: https://europa.eu/!Rf37qt

Reply on Twitter 1546396371355242497Retweet on Twitter 15463963713552424976Like on Twitter 154639637135524249715Twitter 1546396371355242497
Retweet on TwitterIMIBIC-P2Med Retweeted
AvatarMarieSkłodowskaCurie@MSCActions·
9 Jul

12-13 July - the Marie Skłodowska-Curie Actions Satellite Event at #ESOF2022, the largest biennial interdisciplinary meeting on science & innovation in Europe, is happening very soon!

Register now to follow the discussions online and help us spread the word ⤵️

Reply on Twitter 1545686696972275712Retweet on Twitter 154568669697227571221Like on Twitter 154568669697227571245Twitter 1545686696972275712
AvatarIMIBIC-P2Med@IP2med·
1 Jul

We'll be there, You should too! 😎
Online registrations here: https://corporate.idloom.events/msca-satellite-event-online/register

MarieSkłodowskaCurie@MSCActions

On 12 & 13 July the Marie Skłodowska-Curie Actions invite you to the #MSCA at #ESOF2022 online Satellite Event!

Register today and join MSCA fellows, supervisors, coordinators, alumni and policy makers discussing priority topics for the research ecosystem. ⤵️

Reply on Twitter 1542807959675322369Retweet on Twitter 1542807959675322369Like on Twitter 15428079596753223691Twitter 1542807959675322369
AvatarIMIBIC-P2Med@IP2med·
23 Jun

🏆 Our first paper is out! Congratulations André 👏🏽

"Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 as a personalized diagnostic and therapeutic tool"

👀 Read more ⏩ https://p2med.imibic.org/our-first-paper-is-out/

@IMIBIC @ASarmentoCabral @OncMet27

Reply on Twitter 1539960268612059136Retweet on Twitter 15399602686120591361Like on Twitter 153996026861205913613Twitter 1539960268612059136
Load More...
Edificio IMIBIC
Avda Menéndez Pidal s/n
14004 Córdoba
  • +34 957 21 37 16
  • imibic.p2med@imibic.org
Terms of Use and Privacy